Novel Coronavirus (SARS-CoV-2/COVID-19)
The departments of Health and Human Services and Defense will pay Janssen Pharmaceutical Companies of Johnson & Johnson $1 billion to manufacture 100 million doses of its COVID-19 vaccine candidate for use in clinical trials, or to vaccinate Americans if authorized by the Food and Drug…
Patient safety has always been the number one priority for hospitals and health care providers, and COVID-19 has not changed that one bit. In fact, the safety protocols put into place for patients, families, care providers and staff since the pandemic’s onset are the most stringent they’ve ever…
A series of free videos from Med Tac offers guidance on how essential workers and the public can stay safe during the COVID-19 public health emergency.
The AHA, American Medical Association, American Society of Health-System Pharmacists, and United States Pharmacopeia convened a virtual summit to examine the resilience of the U.S. pharmaceutical supply chain in light of the current state of global pharmaceutical manufacturing.
The National Institutes of Health announced clinical trials to investigate the safety and efficacy of a synthetic antibody therapy in COVID-19 patients.
The Centers for Medicare & Medicaid Services will allow health insurers to offer premium reductions for individuals with 2020 coverage in the individual and small group markets when consistent with state law, the agency announced.
The Department of Health and Human Services released specifications for reporting certain COVID-19 laboratory data as required by the Coronavirus Aid, Relief, and Economic Security Act.
The U.S. District Court for the Southern District of New York ruled against the Department of Labor regarding its regulations related to certain expanded paid leave authorized by the Families First Coronavirus Response Act.
President Trump Aug. 3 signed an executive order on “improving rural health and telehealth access,” with directives to: launch a new payment model for rural health care; develop and implement a strategy to improve rural health care infrastructure.
Leading healthcare groups convened a summit, “Safe, Effective, and Accessible High-Quality Medicines as a Matter of National Security,” on July 27-31 to examine the resilience of the U.S. pharmaceutical supply chain in light of the current state of global pharmaceutical manufacturing.